Pfizer Agrees to Cut Drug Prices in Medicaid Deal with Trump Administration
Published on: Oct. 1, 2025, 1:05 a.m. | Source: Devdiscourse
Pfizer has agreed to reduce prices for prescription drugs in the Medicaid program following negotiations with the Trump administration. The deal includes a three-year grace period during which Pfizer's products won't face specific tariffs. Trump aims to implement 'most-favored-nation' pricing to match lower international drug costs.
